These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 2482314)
21. Characterization and epitope mapping of four HLA class II reactive mouse monoclonal antibodies using transfected L cells and human cells transfected with mutants of DQB1*0302. Viken HD; Thorsby E; Gaudernack G Tissue Antigens; 1995 Apr; 45(4):250-7. PubMed ID: 7638861 [TBL] [Abstract][Full Text] [Related]
22. Molecular analysis of HLA class I and class II antigen loss mutants reveals a homozygous deletion of the DR, DQ, and part of the DP region: implications for class II gene order. Erlich H; Lee JS; Petersen JW; Bugawan T; DeMars R Hum Immunol; 1986 Jun; 16(2):205-19. PubMed ID: 3459724 [TBL] [Abstract][Full Text] [Related]
23. Characterization of a monoclonal antibody recognizing a monomorphic determinant of the alpha chain of class II DQ antigens. Fermand JP; Chevalier A; Brouet JC Scand J Immunol; 1986 Sep; 24(3):313-9. PubMed ID: 3529366 [TBL] [Abstract][Full Text] [Related]
24. Immunochemical and functional analysis of HLA class II antigens induced by recombinant immune interferon on normal epidermal melanocytes. Tsujisaki M; Igarashi M; Sakaguchi K; Eisinger M; Herlyn M; Ferrone S J Immunol; 1987 Feb; 138(4):1310-6. PubMed ID: 3100635 [TBL] [Abstract][Full Text] [Related]
26. A new monoclonal antibody recognizing a linear determinant on the HLA-DRalpha chain N-terminus. Ting YT; Temme S; Koch N; McLellan AD Hybridoma (Larchmt); 2009 Dec; 28(6):423-9. PubMed ID: 20025501 [TBL] [Abstract][Full Text] [Related]
27. Expression of HLA-A,B,C, beta 2-microglobulin (beta 2m), HLA-DR, -DP, -DQ and of HLA-D-associated invariant chain (Ii) in soft-tissue tumors. Mechtersheimer G; Staudter M; Majdic O; Dörken B; Moldenhauer G; Möller P Int J Cancer; 1990 Nov; 46(5):813-23. PubMed ID: 2228310 [TBL] [Abstract][Full Text] [Related]
28. Implication of structural class II gene polymorphism for the concept of serologic specificities. Möller E; Carlsson B; Wallin J Immunol Rev; 1985 Jul; 85():107-28. PubMed ID: 2412948 [TBL] [Abstract][Full Text] [Related]
29. [Characteristics of cell membrane of B-lymphocytes in chronic lymphocytic leukemia. I. Expression of class II antigens (HLA-D)]. Pluta A; Górski A; Nowaczyk M Pol Arch Med Wewn; 1991 Sep; 86(3):149-53. PubMed ID: 1725558 [TBL] [Abstract][Full Text] [Related]
30. T cells specific for different antigens express different HLA-D region products. Schendel DJ; Johnson JP Eur J Immunol; 1985 Dec; 15(12):1239-43. PubMed ID: 3878791 [TBL] [Abstract][Full Text] [Related]
31. Major histocompatibility complex (MHC) class II antigen (HLA-DR, DQ, and DP) expression in human fetal endocrine organs and gut. Oliver AM; Thomson AW; Sewell HF; Abramovich DR Scand J Immunol; 1988 Jun; 27(6):731-7. PubMed ID: 3293192 [TBL] [Abstract][Full Text] [Related]
32. HLA-D region alpha-chain monoclonal antibodies: cross-reaction between an anti-DP alpha-chain antibody and smooth muscle. Thomas A; Lindsay J; Wilkinson M; Bodmer J J Pathol; 1988 Apr; 154(4):353-63. PubMed ID: 2455029 [TBL] [Abstract][Full Text] [Related]
33. Expression and function of class II antigens on gastric carcinoma cells and gastric epithelia: differential expression of DR, DQ, and DP antigens. Sakai K; Takiguchi M; Mori S; Kobori O; Morioka Y; Inoko H; Sekiguchi M; Kano K J Natl Cancer Inst; 1987 Nov; 79(5):923-32. PubMed ID: 2960847 [TBL] [Abstract][Full Text] [Related]
34. Detection of antibodies specific for HLA-A,B,C,DR,DQ and DP by the erythrocyte antibody rosette inhibition (EAI) and immune phagocytosis inhibition (IPI) tests. Faust A; Neppert J J Immunol Methods; 1987 Aug; 102(1):71-5. PubMed ID: 3476673 [TBL] [Abstract][Full Text] [Related]
35. Differential expression of HLA-DR, DQ, and DP antigens in primary and metastatic melanoma. van Vreeswijk H; Ruiter DJ; Bröcker EB; Welvaart K; Ferrone S J Invest Dermatol; 1988 May; 90(5):755-60. PubMed ID: 3283252 [TBL] [Abstract][Full Text] [Related]
36. First report on the antibody verification of HLA-DR, HLA-DQ and HLA-DP epitopes recorded in the HLA Epitope Registry. Duquesnoy RJ; Marrari M; Tambur AR; Mulder A; Sousa LC; da Silva AS; do Monte SJ Hum Immunol; 2014 Nov; 75(11):1097-103. PubMed ID: 25305456 [TBL] [Abstract][Full Text] [Related]
37. Detection of HLA-DP serological allodeterminants by the use of radioiodinated DP molecules. Tanigaki N; Tosi R; Parodi B; Sorrentino R; Ferrara GB; Strominger JL Eur J Immunol; 1987 Jun; 17(6):743-50. PubMed ID: 2439347 [TBL] [Abstract][Full Text] [Related]
38. Detection of MHC class II expression on human basophils is dependent on antibody specificity but independent of atopic disposition. Poulsen BC; Poulsen LK; Jensen BM J Immunol Methods; 2012 Jul; 381(1-2):66-9. PubMed ID: 22546486 [TBL] [Abstract][Full Text] [Related]
39. Inhibition of anti-class I cytotoxicity by anti-class II monoclonal antibodies (MoAb). I. Blocking of bulk non-DR and non-DQ-directed cytotoxic T cells by MoAb against DR, DQ, and DP. Strassmann G; Ress S; Anichini A; Bach FH Hum Immunol; 1985 Jun; 13(2):125-37. PubMed ID: 3874193 [TBL] [Abstract][Full Text] [Related]
40. Expression of HLA-DQ, -DR, and -DP antigens in normal kidney and glomerulonephritis. Müller CA; Markovic-Lipkovski J; Risler T; Bohle A; Müller GA Kidney Int; 1989 Jan; 35(1):116-24. PubMed ID: 2468811 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]